对自身免疫性皮肤病应用早期干预策略:机会窗是否处于临床前期?皮肤科-风湿科视角
许多炎症性皮肤病呈慢性病程且长期结局不理想。类风湿关节炎、银屑病关节炎和系统性红斑狼疮的研究提示,最佳机会窗可能延伸至无症状临床前期,且早期与临床前期疾病的致病机制和治疗靶点可能不同于 established disease。本文综述这些见解,并讨论如何在皮肤自身免疫中开展类似研究与治疗策略,重点关注狼疮和银屑病。
要点
- 类风湿关节炎和银屑病关节炎的早期干预时机与强度可影响后期结局。
- 早期及临床前期疾病的致病机制和治疗靶点可能不同于 established disease。
- 狼疮和银屑病等皮肤-风湿科疾病中,有效的早期皮肤病治疗可能对阻止潜在严重系统性疾病有深远影响。
核心结论
- 类风湿关节炎、银屑病关节炎和系统性红斑狼疮的研究提示最佳机会窗可能延伸至无症状临床前期。
- 早期和临床前期疾病可能具有不同于 established disease 的致病机制和治疗靶点。
- 皮肤驻留细胞对既往认为由免疫系统原发和继发淋巴器官启动的疾病有贡献。
- 在狼疮和银屑病中,有效的早期皮肤病治疗可能对阻止潜在严重系统性疾病有深远影响。
研究设计与样本
- 本文为叙述性综述,回顾类风湿关节炎、银屑病关节炎和系统性红斑狼疮早期干预及临床前期机会窗的文献,并讨论在皮肤自身免疫中开展类似研究与治疗策略。
主要发现
- 类风湿关节炎和银屑病关节炎的早期干预时机与强度可影响后期结局。
- 对早期类风湿关节炎、银屑病关节炎和系统性红斑狼疮的研究显示,最佳机会窗可能延伸至无症状临床前期。
- 早期和临床前期疾病可能具有不同于 established disease 的致病机制和治疗靶点。
- 皮肤驻留细胞对既往认为由免疫系统原发和继发淋巴器官启动的疾病有贡献。
关键数值与推荐
- 本文未汇总具体诊断标准或数值阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many inflammatory skin diseases exhibit a chronic course with unsatisfactory long-term outcomes. Insights into early intervention approaches in other autoimmune contexts could improve the trajectory of lifelong diseases in terms of sustained remission or minimal disease activity, reduced requirement for therapy and medical resource use, and improved QoL. In both rheumatoid arthritis (RA) and psoriatic arthritis (PsA), we have learned that the timing and intensity of early interventions can influence later outcomes. Investigation into early RA, PsA, and systemic lupus erythematosus has shown that the optimal window of opportunity may even extend into asymptomatic preclinical phases of diseases. Notably, early and preclinical diseases may have pathogenic mechanisms and therapeutic targets that differ from those of the established disease. In this paper, we review the literature on these insights and discuss how similar research and therapeutic strategies may be investigated in cutaneous autoimmunity. We highlight the contribution of skin-resident cells to diseases that were previously thought to be initiated in the primary and secondary lymphoid organs of the immune system. We focus on two dermato‒rheumatology conditions-lupus and psoriasis-which share the commonality that effective early cutaneous disease therapy may have far-reaching implications on abrogating potentially severe systemic disease.
引用
- Carter LM, McGonagle D, Vital EM, et al. Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective. J Invest Dermatol. 2022. PMID: 35034771. doi:10.1016/j.jid.2021.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。